MIKE DAVID: Open Payments
NPI 1013469295 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,912 in 92 payments from 15 companies in 2025. Trend: 2023 $995 · 2024 $1,121 · 2025 $1,912
Food & beverage: $1,812Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $392 |
| Janssen Biotech, Inc. | 11 | $253 |
| Arcutis Biotherapeutics, Inc. | 14 | $208 |
| Amgen Inc. | 8 | $172 |
| Incyte Corporation | 10 | $171 |
| LEO Pharma Inc. | 11 | $155 |
| GENZYME CORPORATION | 5 | $145 |
| PFIZER INC. | 4 | $104 |
| Cipher Pharmaceuticals US LLC | 1 | $75 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, Zoryve, OTEZLA, OPZELURA, CIBINQO, ADBRY.
Industry payments across NY — which companies pay providers there.
